Literature DB >> 29369424

Non-contrast enhanced 4D intracranial MR angiography based on pseudo-continuous arterial spin labeling with the keyhole and view-sharing technique.

Makoto Obara1, Osamu Togao2, Gabriele M Beck3, Shuhei Shibukawa4,5, Tomoyuki Okuaki5,6, Masami Yoneyama1, Masanobu Nakamura1, Hiroshi Honda2, Marc Van Cauteren6.   

Abstract

PURPOSE: 4D dynamic MR angiography (4D-MRA) using pseudo-continuous arterial spin labeling (pCASL), combined with Keyhole and View-sharing (4D-PACK) for scan acceleration, is introduced. Its validity for arterial inflow dynamics visualization was investigated through comparison with 4D-pCASL and contrast inherent inflow enhanced multiphase angiography (CINEMA).
METHODS: Six healthy volunteers were included in the study. The arterial transit time (ATT) in 4D-PACK was measured at multiple regions in middle cerebral artery (MCA), and Pearson's correlation coefficient with ATT in 4D-pCASL was calculated. The contrast-to-noise ratio (CNR) in 4D-PACK was measured in four MCA segments and compared with that in 4D-pCASL and CINEMA. Arterial visualization in 4D-PACK was assessed qualitatively in patients with moyamoya disease and arteriovenous malformation by comparing with CINEMA.
RESULTS: 4D-PACK achieved a 36% scan time reduction compared with 4D-pCASL. The correlation coefficient for ATT measured by 4D-pCASL and 4D-PACK was greater than 0.96. The CNR was significantly higher using 4D-PACK compared with CINEMA in the M4 segment (P < 0.01). In patient examinations, the flow in the collateral artery or draining vein was better visualized in 4D-PACK compared with CINEMA.
CONCLUSION: 4D-PACK accelerates 4D-pCASL, shows similar inflow dynamics as 4D-pCASL and shows better peripheral visualization compared with CINEMA. Magn Reson Med 80:719-725, 2018.
© 2018 International Society for Magnetic Resonance in Medicine. © 2018 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  4D-MRA; Keyhole; View-sharing; arterial spin labeling; magnetic resonance angiography; pCASL

Mesh:

Year:  2018        PMID: 29369424     DOI: 10.1002/mrm.27074

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  6 in total

1.  4D ASL-based MR angiography for visualization of distal arteries and leptomeningeal collateral vessels in moyamoya disease: a comparison of techniques.

Authors:  Osamu Togao; Akio Hiwatashi; Makoto Obara; Koji Yamashita; Daichi Momosaka; Ataru Nishimura; Koichi Arimura; Nobuhiro Hata; Koji Yoshimoto; Koji Iihara; Marc Van Cauteren; Hiroshi Honda
Journal:  Eur Radiol       Date:  2018-05-08       Impact factor: 5.315

2.  Vessel-Selective 4D-MRA Using Superselective Pseudocontinuous Arterial Spin-Labeling with Keyhole and View-Sharing for Visualizing Intracranial Dural AVFs.

Authors:  O Togao; M Obara; K Kikuchi; M Helle; K Arimura; A Nishimura; T Wada; H Murazaki; M Van Cauteren; A Hiwatashi; K Ishigami
Journal:  AJNR Am J Neuroradiol       Date:  2022-03-03       Impact factor: 3.825

3.  Acceleration of pCASL-Based Cerebral 4D MR Angiography Using Compressed SENSE: A Comparison With SENSE.

Authors:  Maoxue Wang; Yiming Ma; Fei Chen; Fei Zhou; Jilei Zhang; Bing Zhang
Journal:  Front Neurol       Date:  2022-03-21       Impact factor: 4.003

4.  Application Value of Contrast-Enhanced Ultrasound Combined with Enhanced MR Scanning in Patients with Intrahepatic Cholangiocarcinoma.

Authors:  Mingming Zhang; Yan Liu; Lei Han; Guixiang Zhang
Journal:  J Healthc Eng       Date:  2022-03-31       Impact factor: 2.682

Review 5.  Pseudocontinuous Arterial Spin Labeling: Clinical Applications and Usefulness in Head and Neck Entities.

Authors:  Fumine Tanaka; Maki Umino; Masayuki Maeda; Ryohei Nakayama; Katsuhiro Inoue; Ryota Kogue; Makoto Obara; Hajime Sakuma
Journal:  Cancers (Basel)       Date:  2022-08-11       Impact factor: 6.575

6.  Super-selective ASL and 4D ASL-based MR Angiography in a Patient with Moyamoya Disease : Case Report.

Authors:  Nico Sollmann; Hans Liebl; Christine Preibisch; Claus Zimmer; Michael Helle; Makoto Obara; Jan S Kirschke; Stephan Kaczmarz
Journal:  Clin Neuroradiol       Date:  2020-09-25       Impact factor: 3.649

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.